Oxidation of α, β-enones and alkenes with oxone and sodium halides: A convenient laboratory preparation of chlorine and bromine RK Dieter, LE Nice, SE Velu Tetrahedron letters 37 (14), 2377-2380, 1996 | 147 | 1996 |
Attenuation of nonsense-mediated mRNA decay enhances in vivo nonsense suppression KM Keeling, D Wang, Y Dai, S Murugesan, B Chenna, J Clark, ... PloS one 8 (4), e60478, 2013 | 114 | 2013 |
Synthesis of biotin‐tagged chemical cross‐linkers and their applications for mass spectrometry S Kang, L Mou, J Lanman, S Velu, WJ Brouillette, PE Prevelige Jr Rapid Communications in Mass Spectrometry: An International Journal Devoted …, 2009 | 75 | 2009 |
Biochemical and epigenetic insights into L-2-hydroxyglutarate, a potential therapeutic target in renal cancer S Shelar, EH Shim, GJ Brinkley, A Kundu, F Carobbio, T Poston, J Tan, ... Clinical Cancer Research 24 (24), 6433-6446, 2018 | 70 | 2018 |
Identification of novel inhibitors of bacterial surface enzyme Staphylococcus aureus Sortase A BC Chenna, BA Shinkre, JR King, AL Lucius, SVL Narayana, SE Velu Bioorganic & medicinal chemistry letters 18 (1), 380-385, 2008 | 68 | 2008 |
Analogs of the marine alkaloid makaluvamines: Synthesis, topoisomerase II inhibition, and anticancer activity BA Shinkre, KP Raisch, L Fan, SE Velu Bioorganic & medicinal chemistry letters 17 (10), 2890-2893, 2007 | 67 | 2007 |
In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues W Wang, ER Rayburn, SE Velu, DH Nadkarni, S Murugesan, R Zhang Clinical Cancer Research 15 (10), 3511-3518, 2009 | 66 | 2009 |
Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase N Schormann, SE Velu, S Murugesan, O Senkovich, K Walker, ... Bioorganic & medicinal chemistry 18 (11), 4056-4066, 2010 | 56 | 2010 |
Structure‐based approach to pharmacophore identification, in silico screening, and three‐dimensional quantitative structure–activity relationship studies for inhibitors of … N Schormann, O Senkovich, K Walker, DL Wright, AC Anderson, ... Proteins: Structure, Function, and Bioinformatics 73 (4), 889-901, 2008 | 56 | 2008 |
Structure-based discovery of small molecule inhibitors of cariogenic virulence Q Zhang, B Nijampatnam, Z Hua, T Nguyen, J Zou, X Cai, SM Michalek, ... Scientific reports 7 (1), 5974, 2017 | 54 | 2017 |
Cyanobacterial metabolite calothrixins: recent advances in synthesis and biological evaluation S Xu, B Nijampatnam, S Dutta, SE Velu Marine Drugs 14 (1), 17, 2016 | 51 | 2016 |
Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor T Singh, NA Gupta, S Xu, R Prasad, SE Velu, SK Katiyar Oncotarget 6 (25), 21268, 2015 | 51 | 2015 |
Inhibition of Streptococcus mutans Biofilms by the Natural Stilbene Piceatannol Through the Inhibition of Glucosyltransferases B Nijampatnam, H Zhang, X Cai, SM Michalek, H Wu, SE Velu ACS omega 3 (7), 8378-8385, 2018 | 46 | 2018 |
Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential pyrrolidinone ring substituents WJ Brouillette, SN Bajpai, SM Ali, SE Velu, VR Atigadda, BS Lommer, ... Bioorganic & medicinal chemistry 11 (13), 2739-2749, 2003 | 46 | 2003 |
Discovery and characterization of dual inhibitors of MDM2 and NFAT1 for pancreatic cancer therapy W Wang, JJ Qin, S Voruganti, B Nijampatnam, SE Velu, KH Ruan, M Hu, ... Cancer research 78 (19), 5656-5667, 2018 | 45 | 2018 |
Conjugate Addition Reactions of α-Aminoalkylcuprates with α, β-Alkenyl-, α, β-Alkynyl-, α, β− β, γ-Allenyl-, and α, β− γ, δ-Dienyl Carboxylic Acid Derivatives, Nitriles, and … RK Dieter, K Lu, SE Velu The Journal of Organic Chemistry 65 (25), 8715-8724, 2000 | 45 | 2000 |
Experimental Therapy of Ovarian Cancer with Synthetic Makaluvamine Analog: In Vitro and In Vivo Anticancer Activity and Molecular Mechanisms of Action T Chen, Y Xu, H Guo, Y Liu, P Hu, X Yang, X Li, S Ge, SE Velu, ... PLoS One 6 (6), e20729, 2011 | 42 | 2011 |
NAD synthetase inhibitors and uses thereof WJ Brouillette, L Delucas, C Brouillette, SE Velu, YC Kim, L Mou, ... US Patent 6,861,448, 2005 | 42 | 2005 |
MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53 W Wang, JW Cheng, JJ Qin, B Hu, X Li, B Nijampatnam, SE Velu, J Fan, ... Cancer letters 459, 156-167, 2019 | 41 | 2019 |
Hydroxychalcone inhibitors of Streptococcus mutans glucosyl transferases and biofilms as potential anticaries agents B Nijampatnam, L Casals, R Zheng, H Wu, SE Velu Bioorganic & medicinal chemistry letters 26 (15), 3508-3513, 2016 | 41 | 2016 |